Efficacy of Immune Checkpoint Blockade and Biomarkers of Response in Lymphoma: A Narrative Review

Immune checkpoint blockade (ICB) has revolutionized the prognosis of several advanced-stage solid tumors. However, its success has been far more limited in hematological malignancies and is mostly restricted to classical Hodgkin lymphoma (cHL) and primary mediastinal B cell lymphoma (PMBCL). In pati...

Descrición completa

Detalles Bibliográficos

Principais autores:	Sarah Perdikis-Prati, Semira Sheikh, Antonin Bouroumeau, Noémie Lang
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2023-06-01
Series:	Biomedicines
Assuntos:	Hodgkin lymphoma non-Hodgkin lymphoma PD-1/PD-L1 checkpoint inhibitors tumor mutational burden predictive biomarkers
Acceso en liña:	https://www.mdpi.com/2227-9059/11/6/1720
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!